|
1
|
Green KJ, Getsios S, Troyanovsky S and
Godsel LM: Intercellular junction assembly, dynamics, and
homeostasis. Cold Spring Harb Perspect Biol. 2:a0001252010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Angst BD, Marcozzi C and Magee AI: The
cadherin superfamily: diversity in form and function. J Cell Sci.
114:629–641. 2001.PubMed/NCBI
|
|
3
|
Jeanes A, Gottardi CJ and Yap AS:
Cadherins and cancer: how does cadherin dysfunction promote tumor
progression? Oncogene. 27:6920–6929. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nuber UA, Schäfer S, Schmidt A, Koch PJ
and Franke WW: The widespread human desmocollin Dsc2 and
tissue-specific patterns of synthesis of various desmocollin
subtypes. Eur J Cell Biol. 66:69–74. 1995.PubMed/NCBI
|
|
5
|
Chen YJ, Chang JT, Lee L, Wang HM, Liao
CT, Chiu CC, Chen PJ and Cheng AJ: DSG3 is overexpressed in head
neck cancer and is a potential molecular target for inhibition of
oncogenesis. Oncogene. 26:467–476. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fang WK, Liao LD, Li LY, Xie YM, Xu XE,
Zhao WJ, Wu JY, Zhu MX, Wu ZY, Du ZP, Wu BL, Xie D, Guo MZ, Xu LY
and Li EM: Down-regulated desmocollin-2 promotes cell
aggressiveness through redistributing adherens junctions and
activating beta-catenin signalling in oesophageal squamous cell
carcinoma. J Pathol. 231:257–270. 2013. View Article : Google Scholar
|
|
7
|
Kolegraff K, Nava P, Helms MN, Parkos CA
and Nusrat A: Loss of desmocollin-2 confers a tumorigenic phenotype
to colonic epithelial cells through activation of
Akt/{beta}-catenin signaling. Mol Biol Cell. 22:1121–1134. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dusek RL, Getsios S, Chen F, Park JK,
Amargo EV, Cryns VL and Green KJ: The differentiation-dependent
desmosomal cadherin desmoglein 1 is a novel caspase-3 target that
regulates apoptosis in keratinocytes. J Biol Chem. 281:3614–3624.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Khan K, Hardy R, Haq A, Ogunbiyi O, Morton
D and Chidgey M: Desmocollin switching in colorectal cancer. Br J
Cancer. 95:1367–1370. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Anami K, Oue N, Noguchi T, Sakamoto N,
Sentani K, Hayashi T, Hinoi T, Okajima M, Graff JM and Yasui W:
Search for transmembrane protein in gastric cancer by the
Escherichia coli ampicillin secretion trap: expression of
DSC2 in gastric cancer with intestinal phenotype. J Pathol.
221:275–284. 2010.PubMed/NCBI
|
|
11
|
Cui T, Chen Y, Yang L, Mireskandari M,
Knösel T, Zhang Q, Kohler LH, Kunze A, Presselt N and Petersen I:
Diagnostic and prognostic impact of desmocollins in human lung
cancer. J Clin Pathol. 65:1100–1106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hayashi T, Sentani K, Oue N, Anami K,
Sakamoto N, Ohara S, Teishima J, Noguchi T, Nakayama H, Taniyama K,
Matsubara A and Yasui W: Desmocollin 2 is a new immunohistochemical
marker indicative of squamous differentiation in urothelial
carcinoma. Histopathology. 59:710–721. 2011. View Article : Google Scholar
|
|
13
|
Hamidov Z, Altendorf-Hofmann A, Chen Y,
Settmacher U, Petersen I and Knösel T: Reduced expression of
desmocollin 2 is an independent prognostic biomarker for shorter
patients survival in pancreatic ductal adenocarcinoma. J Clin
Pathol. 64:990–994. 2011. View Article : Google Scholar
|
|
14
|
Fang WK, Gu W, Li EM, Wu ZY, Shen ZY, Shen
JH, Wu JY, Pan F, Lv Z, Xu XE, Huang Q and Xu LY: Reduced
membranous and ectopic cytoplasmic expression of DSC2 in esophageal
squamous cell carcinoma: an independent prognostic factor. Hum
Pathol. 41:1456–1465. 2010. View Article : Google Scholar
|
|
15
|
Huen AC, Park JK, Godsel LM, Chen X,
Bannon LJ, Amargo EV, Hudson TY, Mongiu AK, Leigh IM, Kelsell DP,
Gumbiner BM and Green KJ: Intermediate filament-membrane
attachments function synergistically with actin-dependent contacts
to regulate intercellular adhesive strength. J Cell Biol.
159:1005–1017. 2002. View Article : Google Scholar
|
|
16
|
Lewis JE, Wahl JK 3rd, Sass KM, Jensen PJ,
Johnson KR and Wheelock MJ: Cross-talk between adherens junctions
and desmosomes depends on plakoglobin. J Cell Biol. 136:919–934.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Garrod D and Chidgey M: Desmosome
structure, composition and function. Biochim Biophys Acta.
1778:572–587. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hartlieb E, Kempf B, Partilla M, Vigh B,
Spindler V and Waschke J: Desmoglein 2 is less important than
desmoglein 3 for keratinocyte cohesion. PLoS One. 8:e537392013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mannan T, Jing S, Foroushania SH, Fortune
F and Wan H: RNAi-mediated inhibition of the desmosomal cadherin
(desmoglein 3) impairs epithelial cell proliferation. Cell Prolif.
44:301–310. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vasioukhin V, Bowers E, Bauer C,
Degenstein L and Fuchs E: Desmoplakin is essential in epidermal
sheet formation. Nat Cell Biol. 3:1076–1085. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bass-Zubek AE, Hobbs RP, Amargo EV, Garcia
NJ, Hsieh SN, Chen X, Wahl JK 3rd, Denning MF and Green KJ:
Plakophilin 2: a critical scaffold for PKC alpha that regulates
intercellular junction assembly. J Cell Biol. 181:605–613. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Godsel LM, Dubash AD, Bass-Zubek AE,
Amargo EV, Klessner JL, Hobbs RP, Chen X and Green KJ: Plakophilin
2 couples actomyosin remodeling to desmosomal plaque assembly via
RhoA. Mol Biol Cell. 21:2844–2859. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Acehan D, Petzold C, Gumper I, Sabatini
DD, Müller EJ, Cowin P and Stokes DL: Plakoglobin is required for
effective intermediate filament anchorage to desmosomes. J Invest
Dermatol. 128:2665–2675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Todorović V, Desai BV, Patterson MJ,
Amargo EV, Dubash AD, Yin T, Jones JC and Green KJ: Plakoglobin
regulates cell motility through Rho- and fibronectin-dependent Src
signaling. J Cell Sci. 123:3576–3586. 2010.PubMed/NCBI
|
